Case of Suspected SARS-CoV-2 Vaccine-induced Immune Thrombotic Thrombocytopenia: Dilemma for Organ Donation

JOURNAL TITLE: Indian Journal of Critical Care Medicine

Author
1. Rupali S Suryawanshi
2. Lomesh B Bhirud
3. Shilpa S Kulkarni
4. Sushma K Gurav
ISSN
0972-5229
DOI
10.5005/jp-journals-10071-24184
Volume
26
Issue
4
Publishing Year
2022
Pages
4
Author Affiliations
    1. Neuro Trauma Unit, Grant Medical Foundation, Pune, Maharashtra, India
    1. Department of Neurology, Grant Medical Foundation, Pune, Maharashtra, India
    1. Department of Laboratory, Grant Medical Foundation, Pune, Maharashtra, India
    1. Department of Critical Care, Ruby Hall Clinic, Pune, Maharashtra, India
  • Article keywords
    Cerebral venous sinus thrombosis, COVID vaccine, Organ donation, PF4 antibody, Thrombocytopenia, Vaccine-induced prothrombotic immune thrombocytopenia (VIPIT), Vaccine-induced thrombotic thrombocytopenia (VITT)

    Abstract

    Several vaccines were developed and rolled out at an unprecedented rate in response to the coronavirus disease-2019 (COVID-19) pandemic. Most vaccines approved globally by WHO for emergency use to combat the pandemic were deemed remarkably effective and safe. Despite the safety, rare incidences of vaccine-induced thrombosis and thrombocytopenia (VITT), sometimes known as vaccine-induced prothrombotic thrombocytopenia (VIPIT), have been reported. We report a case of young female with prothrombotic conditions and suspected VITT who developed catastrophic cerebral venous sinus thrombosis (CVST) and progressed to brain death. We highlight hurdles of organ retrieval from a brain-dead patient with suspected SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. There is limited data and lack of substantial evidence regarding transplantation of organs from brain-dead patients with suspected VITT.

    © 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved